Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial
Yichuan Yuan(Central University of Finance and Economics), Xiaozhong Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Ruhai Zou(Sun Yat-sen University), Binkui Li(Sun Yat-sen University), Wan Yee Lau(Chinese University of Hong Kong), Bin Chen(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Chenwei Wang(Baylor College of Medicine), Wei He(Chinese University of Hong Kong), Jiliang Qiu(Sun Yat-sen University), Yun Zheng(Sichuan University)
Cited by 8
Related Papers
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
|eLife|2012|2.1k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2005|591